Physician

Michael Edward Tschickardt, M.D.

According to 2025 Medicare claims, Michael Tschickardt, M.D. (NPI: 1477565208) practices interventional pain management (ipm) in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is MICHAEL E. TSCHICKARDT, M.D., P.A. (NPI: 1861513863; TIN: 203960286) and primary practice location at 78412-4947. Tschickardt is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Tschickardt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 609 traditional Medicare patients, billed 48,502 HCPCS/CPT codes, and received $375,906 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 1,794 prescription claims across 379 beneficiaries totaling $98,042 in drug costs, led by Xtampza Er (Oxycodone Myristate). 2016 DME data shows 11 claims. Open Payments data shows 57 records totaling $1,534. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $680,692 to $98,042. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	928	12,906	$456,106
2016	819	9,892	$412,848
2017	795	9,076	$426,433
2018	750	50,289	$412,908
2019	707	53,469	$441,100
2020	661	46,013	$361,414
2021	672	56,016	$499,244
2022	750	30,382	$566,783
2023	738	28,856	$573,370
2024	609	48,502	$375,906

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	796	8,542	$680,692
2016	667	7,477	$570,531
2017	577	6,710	$494,914
2018	562	6,074	$427,752
2019	547	6,720	$518,636
2020	481	5,439	$395,895
2021	412	4,181	$301,837
2022	315	3,166	$255,818
2023	328	2,987	$233,803
2024	379	1,794	$98,042

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$379
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	182	220	$221
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	434	882	$63
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	278	1,840	$1
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	417	40,792	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	181	2,230	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	66	1,980	$36,949
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	758	22,064	$17,351
Fentanyl	Fentanyl	70	2,099	$10,182
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	260	7,387	$6,484
Morphine Sulfate Er	Morphine Sulfate	191	5,719	$6,225

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$1,534	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Edward Tschickardt, M.D.?

Tedicare shows public-source Medicare data for Michael Edward Tschickardt, M.D. (NPI 1477565208), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Edward Tschickardt, M.D. have ACO affiliation data?

Michael Edward Tschickardt, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Michael Edward Tschickardt, M.D.?

Michael Edward Tschickardt, M.D. is linked to MICHAEL E. TSCHICKARDT, M.D., P.A. (billing NPI 1861513863) in the available physician profile data.

Does Michael Edward Tschickardt, M.D. have Open Payments data?

Michael Edward Tschickardt, M.D. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.